| Type 2 diabetes E Ahmad, S Lim, R Lamptey, DR Webb, MJ Davies The Lancet 400 (10365), 1803-1820, 2022 | 355 | 2022 |
| Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus M Ibrahim, MJ Davies, E Ahmad, FA Annabi, RH Eckel, EM Ba-Essa, ... BMJ Open Diabetes Research and Care 8 (1), e001248, 2020 | 113 | 2020 |
| Where does metformin stand in modern day management of type 2 diabetes? E Ahmad, JA Sargeant, F Zaccardi, K Khunti, DR Webb, MJ Davies Pharmaceuticals 13 (12), 427, 2020 | 32 | 2020 |
| Type 2 diabetes and impaired physical function: a growing problem E Ahmad, JA Sargeant, T Yates, DR Webb, MJ Davies Diabetology 3 (1), 30-45, 2022 | 26 | 2022 |
| Hypothyroidism conversion to hyperthyroidism: it’s never too late E Ahmad, K Hafeez, MF Arshad, J Isuga, A Vrettos Endocrinology, Diabetes & Metabolism Case Reports 2018 (1), 2018 | 23 | 2018 |
| Association between SGLT2 inhibitor treatment and diabetic ketoacidosis and mortality in people with type 2 diabetes admitted to hospital with COVID-19 K Khunti, Y Ruan, J Davies, BCT Field, S Harris, M Kosiborod, D Nagi, ... Diabetes Care 45 (12), 2838-2843, 2022 | 17 | 2022 |
| Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity … E Ahmad, HL Waller, JA Sargeant, MBA Webb, ZZ Htike, GP McCann, ... Diabetes, Obesity and Metabolism 23 (6), 1409-1414, 2021 | 13 | 2021 |
| Exercise, pharmaceutical therapies and type 2 diabetes: looking beyond glycemic control to whole body health and function T Yates, J Henson, J Sargeant, J King, E Ahmad, F Zaccardi, M Davies Loughborough University, 2021 | 10 | 2021 |
| Cancer is becoming the leading cause of death in diabetes–Authors' reply MJ Davies, E Ahmad, S Lim, R Lamptey, DR Webb The Lancet 401 (10391), 1849-1850, 2023 | 9 | 2023 |
| The effects of weight‐lowering pharmacotherapies on physical activity, function and fitness: A systematic review and meta‐analysis of randomized controlled trials R Jobanputra, JA Sargeant, A Almaqhawi, E Ahmad, F Arsenyadis, ... Obesity Reviews 24 (4), e13553, 2023 | 6 | 2023 |
| Status dystonicus: a diagnosis delayed MF Arshad, E Ahmad, AN Biddanda, M Sharif Case Reports 2018, bcr-2018-226531, 2018 | 5 | 2018 |
| Atraumatic splenic rupture after myocardial infarction MF Arshad, N Javed, SM Karim, E Ahmad, NUA Abid European Journal of Case Reports in Internal Medicine 5 (4), 2018 | 5 | 2018 |
| Primary diffuse leptomeningeal gliomatosis: radiological/pathological features E Ahmad, M Mohamed, A Vrettos Case Reports in Neurological Medicine 2016 (1), 5016840, 2016 | 5 | 2016 |
| Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus M Ibrahim, MM Barker, E Ahmad, A Ahmed, FA Annabi, EM Ba‐Essa, ... Diabetes/Metabolism Research and Reviews 39 (3), e3604, 2023 | 4 | 2023 |
| Initiation of new glucose-lowering therapies may act to reduce physical activity levels: pooled analysis from three randomized trials T Yates, JA Sargeant, JA King, J Henson, CL Edwardson, E Redman, ... Diabetes care 45 (11), 2749-2752, 2022 | 4 | 2022 |
| The effects of omega-3 supplementation on depression in adults with cardiometabolic disease: A systematic review of randomised control trials F Arsenyadis, E Ahmad, E Redman, T Yates, M Davies, K Khunti Nutrients 14 (9), 1827, 2022 | 4 | 2022 |
| Mycobacterium avium-intracellulare septic arthritis of the sternoclavicular joint in an immunocompetent host; a three-year follow-up A Vrettos, M Prasinou, E Ahmad, D Malamis, A Khan Indian Journal of Tuberculosis 66 (3), 422-426, 2019 | 3 | 2019 |
| Regional Health Care Programme Partnering General Practitioners to Reduce Low Acuity Attendance at the Emergency Department: GPFirst LSH Chin, HC Oh, P Goh, EA Ahmad, N Venkataraman, CH How ANNALS OF EMERGENCY MEDICINE 80 (4), S40-S40, 2022 | 2 | 2022 |
| A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID‐19 BCT Field, Y Ruan, KA Várnai, J Davies, REJ Ryder, R Gandhi, S Harris, ... Diabetes, Obesity and Metabolism 25 (7), 2012-2022, 2023 | 1 | 2023 |
| Impact of novel glucose‐lowering therapies on physical function in people with type 2 diabetes: A systematic review and meta‐analysis of randomised placebo‐controlled trials E Ahmad, F Arsenyadis, A Almaqhawi, M Barker, R Jobanputra, ... Diabetic Medicine 40 (6), e15083, 2023 | 1 | 2023 |
